Additional file 1 of EAF2 Downregulation Recruits Tumor-associated Macrophages in Prostate Cancer through Upregulation of MIF

Supplementary Figure 1: Expression of EAF2 in various tumors and normal tissues. ACC, Adrenocortical carcinoma. BLCA, Bladder Urothelial Carcinoma. BRCA, Breast invasive carcinoma. CESC, Cervical squamous cell carcinoma and endocervical adenocarcinoma. CHOL, Cholangiocarcinoma. COAD, Colon adenocarcinoma. DLBC, Lymphoid Neoplasm Diffuse Large B-cell Lymphoma. ESCA, Esophageal carcinoma. GBM, Glioblastoma multiforme. HNSC, Head and Neck squamous cell carcinoma. KICH, Kidney Chromophobe. KIRC, Kidney renal clear cell carcinoma. KIRP, Kidney renal papillary cell carcinoma. LAML, Acute Myeloid Leukemia. LGG, Brain Lower Grade Glioma. LIHC, Liver hepatocellular carcinoma. LUAD, Lung adenocarcinoma. LUSC, Lung squamous cell carcinoma. MESO, Mesothelioma. OV, Ovarian serous cystadenocarcinoma. PAAD, Pancreatic adenocarcinoma. PCPG, Pheochromocytoma and Paraganglioma. PRAD, Prostate adenocarcinoma. READ, Rectum adenocarcinoma. SARC, Sarcoma. SKCM, Skin Cutaneous Melanoma. STAD, Stomach adenocarcinoma. TGCT, Testicular Germ Cell Tumors. THCA, Thyroid carcinoma. THYM, Thymoma. UCEC, Uterine Corpus Endometrial Carcinoma. UCS, Uterine Carcinosarcoma. UVM, Uveal Melanoma